$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-19-000490 Size: 4 KB 网页链接
$Recro制药(REPH)$ 8-K Current report, item 5.02 Accession Number: 0001193125-19-308407 Act: 34 Size: 17 KB 网页链接
$Recro制药(REPH)$ 8-K Current report, items 1.01, 2.01, and 9.01 Accession Number: 0001193125-19-301244 Act: 34 Size: 567 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-19-000443 Act: 34 Size: 6 KB 网页链接
$Recro制药(REPH)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-19-290504 Act: 34 Size: 5 MB 网页链接
$Recro制药(REPH)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001192482-19-000404 Act: 34 Size: 3 KB 网页链接
$Recro制药(REPH)$ 8-K - Current report Filed: 2019-11-08 AccNo: 0001193125-19-287810 Size: 144 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Recro制药(REPH)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-08 AccNo: 0001564590-19-042010 Size: 10 MB 网页链接
$Recro制药(REPH)$ 8-K - Current report Filed: 2019-11-05 AccNo: 0001193125-19-284014 Size: 38 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro制药(REPH)$ 8-K - Current report Filed: 2019-10-31 AccNo: 0001193125-19-279889 Size: 54 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接